Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
5
100%

Phase Distribution

5

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
5(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 15 (100.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_1

A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer

NCT02176746
completedphase_1

The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine

NCT02115958
completedphase_1

Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer

NCT02074046
completedphase_1

Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients

NCT02089919
completedphase_1

Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells

NCT02084823

Clinical Trials (5)

Showing 5 of 5 trials
NCT02176746Phase 1

A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer

Completed
NCT02115958Phase 1

The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine

Completed
NCT02074046Phase 1

Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer

Completed
NCT02089919Phase 1

Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients

Completed
NCT02084823Phase 1

Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells

Completed

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5